Remicade 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCY3X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,794
Award facts
- Contract value 100% obligated
- $27,794.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,794.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Remicade, a biologic medication used to treat inflammatory conditions. The award, issued on January 7, 2026, with an ultimate completion date of January 8, 2026, represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements through open competition.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical supply chain, supplying pharmaceutical products and medical supplies primarily to military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its versatility in fulfilling diverse medical procurement needs across multiple therapeutic domains. As a major pharmaceutical distributor operating under the DLA's comprehensive global pharmaceutical support vehicle, AmerisourceBergen is positioned to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with brand-name and generic medications, vaccines, and specialized medical supplies required by military treatment facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FCY3X?
SPE2DR26FCY3X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FCY3X worth?
The government has obligated $27,794 on SPE2DR26FCY3X.
Is contract SPE2DR26FCY3X an order under another contract?
Yes. SPE2DR26FCY3X is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY3X competed?
The extent of competition for SPE2DR26FCY3X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award